Transfer Factor RioVida juice with Açaí Berry
The new Transfer Factor Riovida juice based primarily on the Acai Berry, is exploding into the health beverage industry which is one of the fastest-growing segments of worldwide commerce today.
Led by prominent health beverages such as XanGo (mangosteen based), Tahitian Noni (noni fruit based), Aloe Vera led by Forever Living Products (ale vera based), MonaVie (acai based) and Fruta Vida (acai based), these and many other competing products have sprung up in reaction to this growing market.
These products will not be able to compete with RioVida because it is powered by liquid Transfer Factor. After 5 years of development, 4Life Research has been able to create a stabilized form
of the patented Transfer Factor molecule.
The new 4Life Transfer Factor
RioVida captures the proven immune power of 4Life Transfer Factor in an exotic
swirl of fruits and berries from around the world. In addition to
Acai
Berry Juice, it also contains
Elderberry Juice,
Blueberry Juice,
Pomegranate Juice,
Grape Juice,
Lactoferrin and
Vitamin
C.
This pure RioVida juice is bursting with the vitality of Acai, deep
purple berries from the Brazilian rainforest so packed with nutrition they are
often called nature’s energy fruit. Pomegranates, blueberries, elderberries and
grapes add their potency to the blend, making RioVida as rich in antioxidants as
it is in flavor.
Key Points
• Transfer factors: One of the strongest forces in nature for transferring
and ensuring good health, transfer factors have
taken their place in the forefront of nutritional supplement science. Transfer
factors are tiny molecules that transfer immunity
information from one entity to another, such as between a mother and her infant
who she breastfeeds. Transfer factors educate
your immune system, thus supporting the recognition phase of an infection. This
provides the necessary support for the immune
system to be able to remember healthy immune function.
Developed exclusively by 4Life, using patented and patent-pending technology,
our Transfer Factor E-XF proprietary blend calls
upon the knowledge of two sources, providing an enhanced combined effect of
transfer factors from both cow colostrum and egg
yolks. Research shows that the immune-supporting effects of this transfer factor
blend are more potent than that of colostrum or
egg sources alone.
• Scientifically Studied: 4Life researchers and scientists developed this
Advanced Formula in an effort to further maximize
immune system support using transfer factor molecules. Results of an independent
study conducted at the Russian Academy
of Medical Science conclusively showed the ability of 4Life Transfer Factor
Advanced Formula to boost Natural Killer (NK) cell
activity to 283 percent above normal immune response.
• Shared Immune Knowledge: The two most abundant and safest sources of transfer
factors come from cow colostrum and egg
yolks. Transfer factor molecules can be shared safely and effectively. Whether
they are transferred from cow to human or from
chicken to human, transfer factors are not species specific.
With transfer factors you have the ability to borrow immune memory from the cow
and chicken, so when you come in contact
with the same organisms, you have an incredible advantage—your system is ready
to remember, recognize and respond more
effectively. The Transfer Factor E-XF proprietary blend found in 4Life Transfer
Factor Advanced Formula and 4Life Transfer Factor
Chewable combines polyvalent transfer factors from both the cow and chicken for
synergistic immune system support unlike any
other product available today.
• Systemic and Active Nature: The small molecular weight of transfer factors
allows them to be absorbed into the bloodstream,
which enables them to work freely throughout the entire body. They provide
continuous support to the immune system because
their immune messages are passed to immune cells, which have several weeks of
life within the body. Transfer factors support
healthy cellular immune functions.
Did you know?
Transfer factors were first discovered in 1949 by Dr. H. Sherwood Lawrence.
Since that time, hundreds of clinical studies and papers
have been published on transfer factors, at a cost of over $40 million.
The Centers for Disease Control (CDC) has estimated that one half of the more
than 100 million yearly prescriptions for antibiotics
are for non-bacterial conditions where antibiotics would be ineffective. This
alarming trend has greatly contributed to the amount
of antibiotic resistance.